[ccpw id="5"]

Home.forex news reportTesla (TSLA) Gains Wall Street Attention as GLJ Maintains Sell Rating

Tesla (TSLA) Gains Wall Street Attention as GLJ Maintains Sell Rating

-


Tesla, Inc. (NASDAQ:TSLA) is one of the AI Stocks Gaining Attention on Wall Street. On January 7, GLJ Research analyst Gordon Johnson raised the price target on the stock to $25.28 (from $19.05) while maintaining a “Sell” rating. The firm has cited concerns about Tesla’s core automotive business, describing it as “fledgling.”

The automotive business, as per the firm’s estimates, represents 72.2% of sales. These numbers have been deemed “fledgling” even though they it projects a decent 12.1% year-over-year growth in the Energy Generation & Storage segment at 31.2% margins.

Pixabay/Public Domain

GLJ noted that Tesla experienced it’s first-ever year-over-year global delivery decline in 2024, falling 1.1%. It anticipates steeper declines of 7.7% in 2025 and 15.0% in 2026, driven by U.S. EV tax credit benefits fully rolling off, intensifying Chinese competition, and sustained brand erosion in Europe.

When viewing Tesla’s deliveries through actual deliveries and rising discounts, the firm noted how its sum-of-the-parts analysis show Tesla’s earnings outlook deteriorates quickly.

Tesla, Inc. (NASDAQ:TSLA) is an automotive and clean energy company that leverages advanced artificial intelligence in its autonomous driving technology and robotics initiatives.

While we acknowledge the potential of TSLA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 11 AI Stocks on the Market’s Radar and 10 AI Stocks Analysts Are Watching Closely

Disclosure: None.



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

LATEST POSTS

What Investors Should Know About a $511K Disc Medicine Insider Sale and a 26% Stock Run

The chief legal officer of Disc Medicine sold 6,500 shares of the company for $511,472 on Jan....

‘Big Short’ Investor Michael Burry Bets Against Oracle—Here’s His Advice

Michael Burry, the investor who famously bet against the US housing market during the 2008 financial crisis, has turned bearish on Oracle Corporation (NYSE:ORCL). ...

Can This Stock Double Again in 2026?

Structure Therapeutics' positive phase 2 data for aleniglipron sent its stock price soaring last year. ...

2 Dominant Tech Stocks to Buy in January and Hold for 5 Years

Investors continue to underestimate just how profitable Amazon can become over time. Strong demand for...

Follow us

0FansLike
0FollowersFollow
0SubscribersSubscribe

Most Popular

spot_img